Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
05/2012
05/29/2012US8188104 Anti-infective agents and uses thereof
05/29/2012US8188103 Substituted 2-alkyl quinazolinone derivatives as PARP inhibitors
05/29/2012US8188095 Gyrase inhibitors and uses thereof
05/29/2012US8188091 Tetrahydroquinazoline compounds and their use in preparing medicaments for treating and preventing virosis
05/29/2012US8188087 Crystalline (3-cyano-1H-indol-7-yl)-[4-(4-fluorophenethyl) piperazin-1-yl]methanone phosphate
05/29/2012US8188085 Antifungal agents
05/29/2012US8188084 Pyridinone and pyridazinone derivatives as inhibitors of poly (ADP-ribose) polymerase (PARP)
05/29/2012US8188064 Reducing cell differentiation of adipocyte; reducing body fat
05/29/2012US8187727 Imidazole derivatives, preparation method thereof and organic electronic device using the same
05/29/2012US8187607 Hapten-carrier conjugates and uses thereof
05/29/2012CA2687927C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
05/29/2012CA2555624C Thioamide compounds or salts thereof and cytokine production inhibitors containing the same
05/29/2012CA2542140C Crystalline forms of {2-[1-(3,5-bis-trifluoromethylbenzyl)-5-pyridin-4-yl-1h-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
05/29/2012CA2531210C Imidazole derivatives and their use in the treatment of mglur5 receptor mediated disorders
05/29/2012CA2502219C A process for producing an amorphous isomer of lansoprazole
05/29/2012CA2496127C Piperidinyl compounds that selectively bind integrins
05/29/2012CA2490972C Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
05/29/2012CA2483998C Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
05/29/2012CA2463966C Pyrazolyl-substituted heterocycles and their use as phytosanitary products
05/29/2012CA2318731C Ppar-gamma modulators
05/24/2012WO2012068468A1 Method of treatment with braf inhibitor
05/24/2012WO2012068343A1 Quinoline derivatives as pik3 inhibitors
05/24/2012WO2012067963A1 Nampt inhibitors
05/24/2012WO2012067863A1 Heterocyclic compounds as imaging probes of tau pathology
05/24/2012WO2012066122A1 2 - (pyridin- 2 -yl) -quinazoline derivatives and their use as microbicides
05/24/2012WO2012066095A1 Crystalline form of an inhibitor of mdm2/4 and p53 interaction
05/24/2012WO2012066077A1 1,4 di substituted pyrrolidine - 3 - yl -amine derivatives and their use for the treatment of metabolic disorders
05/24/2012WO2012065963A2 Novel antiviral compounds
05/24/2012WO2012065904A2 Cyanoenamines and their use as fungicides
05/24/2012WO2012065568A1 Azo heterocyclic compound having insecticidal activity, and preparation and applications thereof
05/24/2012WO2012065527A1 Compouds and uses as l-type calcium channel blocker and/or acetylcholinesterase inhibitor thereof
05/24/2012WO2012021409A3 Anthraquinone Analogs
05/24/2012WO2012012612A3 Tetrazine-trans-cyclooctene ligation for the rapid construction of radionuclide labeled probes
05/24/2012WO2011133728A3 Anti-viral compounds
05/24/2012WO2011051540A8 Androgen receptor modulating compounds
05/24/2012US20120130080 Process for preparing 2-amino-5-cyanobenzoic acid derivatives
05/24/2012US20120130078 Indazole derivatives as adenosine monophosphate deaminase (ampd) inhibitors for use in diabetes and related diseases of metabolic syndrome
05/24/2012US20120130076 Synthetic Multimerizing Agents
05/24/2012US20120130069 Novel indazole derivatives or pharmaceutically acceptable salts thereof as protein kinase inhibitors for proliferative diseases treatment, and a pharmaceutical composition containing the same as an active ingredient
05/24/2012US20120129893 Inhibition Of Raf Kinase Using Substituted Heterocyclic Ureas
05/24/2012US20120129892 Novel pharmaceutically acceptable salts of 4-(1h-imidazol-4-ylmethyl)pyridine and their therapeutical uses
05/24/2012US20120129890 Indole derivative or pharmaceutically acceptable salt thereof
05/24/2012US20120129888 Libraries of n-(2-oxo-1-phenylpiperidin-3-yl)sulfonamides for drug discovery
05/24/2012US20120129886 Metalloenzyme inhibitor compounds
05/24/2012US20120129875 Substituted quinazolines as fungicides
05/24/2012US20120129871 Crystalline form of an inhibitor of MDM2/4 and p53 interaction
05/24/2012US20120129870 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor
05/24/2012US20120129864 Substituted 1-alkylcinnolin-4(1h)-one derivatives, preparation thereof and therapeutic application of same
05/24/2012US20120129859 Preparation of 1-(substituted benzyl)-5-trifluoromethyl-2(1h)pyridone compounds and salts thereof and their applications
05/24/2012US20120129856 Compounds, compositions and methods useful for cholesterol mobilisation
05/24/2012US20120129854 Pesticidal Arylpyrrolidines
05/24/2012US20120129845 Inhibitors of Bruton's Tyrosine Kinase
05/24/2012US20120129844 N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and salts thereof
05/24/2012US20120129840 Novel viral replication inhibitors
05/24/2012US20120129837 Derivatives of Fluorene, Anthracene, Xanthene, Dibenzosuberone and Acridine and Uses Thereof
05/24/2012US20120129830 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof and therapeutic use thereof
05/24/2012US20120129827 Novel derivatives of 1-alkyl-6-oxo-piperidine-3-carboxylic acids and 1-alkyl-5-oxo-pyrrolidine-3-carboxylic acids and their uses as cooling compounds
05/24/2012US20120129812 Novel thyroid hormone beta receptor agonist
05/24/2012US20120128630 1-(6 members azo-heterocyclic)-pyrrolin-2-one compounds as inhibitors of hepatitis c ns5b polymerase, the pharamaceutical composition thereof and their therapeutic use
05/24/2012US20120126221 Charge-transporting material and organic electroluminescence device
05/24/2012US20120125439 Photoelectrochemical Solar Cell Comprising Sensitizing Anthocyanin And Betalain Dyes Of Vegetal Or Synthetic Origin, Or Mixtures Thereof
05/24/2012CA2818361A1 3'-deutero-pomalidomide
05/24/2012CA2818025A1 Pyridazine derivatives, compositions and methods for treating cognitive impairment
05/24/2012CA2817521A1 Heterocyclic compounds as imaging probes of tau pathology
05/24/2012CA2817165A1 Novel antiviral compounds
05/24/2012CA2817093A1 Nampt inhibitors
05/24/2012CA2816810A1 Crystalline form of an inhibitor of mdm2/4 and p53 interaction
05/24/2012CA2816144A1 Quinoline derivatives as pik3 inhibitors
05/24/2012CA2814826A1 Bridged spiro[2.4]heptane ester derivatives
05/23/2012EP2455377A1 Synthesis of fentanyl analogs
05/23/2012EP2455376A1 Heterocyclic compounds as inhibitors of hepatitis C virus (HCV)
05/23/2012EP2454254A2 Benzimidazole analogues for the treatment or prevention of flavivirus infections
05/23/2012EP2454253A1 Aminopyridine derivatives for treating tumors and inflammatory diseases
05/23/2012EP2454252A1 Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction
05/23/2012EP2454251A1 Gpr119 agonists
05/23/2012EP2454250A1 Apoptosis signal-regulating kinase inhibitors
05/23/2012EP2454239A1 Substituted triazole and imidazole derivatives as gamma secretase modulators
05/23/2012EP2454237A1 3-0x0-2, 3, -dihydro-1h-isoindole-4-carboxamides with selective parp-1 inhibition
05/23/2012EP2454236A1 3-oxo-2, 3-dihydro-1h-isoindole-4-carboxamides as parp inhibitors
05/23/2012EP2453894A1 Crystalline freebase forms of a biphenyl compound
05/23/2012EP2209373B1 N-substituted oxindoline derivatives as calcium channel blockers
05/23/2012EP2197842B1 2, 3-substituted indole derivatives for treating viral infections
05/23/2012EP2027096B1 Substituted arylimidaz0l0ne and triaz0l0ne as inhibitors of vasopressin receptors
05/23/2012EP1474408B1 N-phenyl-2-pyrimidine-amine derivatives
05/23/2012CN1561340B Novel 1,2,4-triazole compound
05/23/2012CN102473858A Material for organic electroluminescent element, and organic electroluminescent element using same
05/23/2012CN102471324A 作为丙型肝炎病毒抑制剂的双苯并咪唑衍生物 Bis-benzimidazole derivatives as inhibitors of hepatitis C virus
05/23/2012CN102471323A 苯基乙炔基衍生物作为丙型肝炎病毒抑制剂 Phenylethynyl derivatives as inhibitors of hepatitis C virus
05/23/2012CN102471319A Jnk的抑制剂 Jnk inhibitors
05/23/2012CN102471318A 适用于用作锕系元素配体的化合物、其合成及应用 Compounds suitable for use as actinide ligands, the synthesis and application
05/23/2012CN102471317A 用于治疗肿瘤和炎性疾病的氨基吡啶衍生物 For the treatment of cancer and inflammatory diseases aminopyridine derivative
05/23/2012CN102471316A 杀虫化合物 Insecticidal compounds
05/23/2012CN102471315A 制备4-氨基丁-2-烯羟酸内酯的新方法 4-amino-2-ene-carboxylic acid lactone new method for preparing
05/23/2012CN102471314A 适合于特别是睡眠障碍和药物成瘾的治疗的螺氨基化合物 Particularly suitable for sleep disorders and drug addiction treatment spiro-amino compound
05/23/2012CN102471313A Gpr119激动剂 Gpr119 agonists
05/23/2012CN102471311A 除草活性杂环芳基取代的环二酮或其衍生物 The herbicidal activity of the aryl group substituted with a heterocyclic ring or a derivative thereof dione
05/23/2012CN102471310A 用于治疗增生性疾病的联吡啶化合物 For the treatment of proliferative diseases bipyridyl compound
05/23/2012CN102471309A 作为mglur5拮抗物的咪唑衍生物 As antagonists of the imidazole derivative mglur5
05/23/2012CN102471287A 2-氨基-5-三氟甲基嘧啶衍生物的区域选择性制备方法 2-amino-5-trifluoromethyl-pyrimidine derivatives regioselective preparation of
05/23/2012CN102471284A 作为p2x7调节剂的二氢嘧啶酮酰胺 As dihydropyrimidinone amide p2x7 moderator
1 ... 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 ... 1080